GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Return-on-Tangible-Asset

Smith & Nephew (Smith & Nephew) Return-on-Tangible-Asset : 3.17% (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Smith & Nephew Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Smith & Nephew's annualized Net Income for the quarter that ended in Dec. 2023 was $182 Mil. Smith & Nephew's average total tangible assets for the quarter that ended in Dec. 2023 was $5,750 Mil. Therefore, Smith & Nephew's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 was 3.17%.

The historical rank and industry rank for Smith & Nephew's Return-on-Tangible-Asset or its related term are showing as below:

SNN' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 3.82   Med: 12.07   Max: 23.09
Current: 4.53

During the past 13 years, Smith & Nephew's highest Return-on-Tangible-Asset was 23.09%. The lowest was 3.82%. And the median was 12.07%.

SNN's Return-on-Tangible-Asset is ranked better than
65.78% of 865 companies
in the Medical Devices & Instruments industry
Industry Median: -2.31 vs SNN: 4.53

Smith & Nephew Return-on-Tangible-Asset Historical Data

The historical data trend for Smith & Nephew's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Return-on-Tangible-Asset Chart

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.69 7.76 7.98 3.65 4.54

Smith & Nephew Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.83 5.76 1.60 6.08 3.17

Competitive Comparison of Smith & Nephew's Return-on-Tangible-Asset

For the Medical Devices subindustry, Smith & Nephew's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Return-on-Tangible-Asset falls into.



Smith & Nephew Return-on-Tangible-Asset Calculation

Smith & Nephew's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=263/( (5699+5885)/ 2 )
=263/5792
=4.54 %

Smith & Nephew's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=182/( (5615+5885)/ 2 )
=182/5750
=3.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2023) net income data.


Smith & Nephew  (NYSE:SNN) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Smith & Nephew Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew (Smith & Nephew) Business Description

Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus

Smith+Nephew acquires novel cementless partial knee system

By PRNewswire PRNewswire 01-19-2022